Saturday Rounds: Week of September 13-18, 2026

Two rare-disease approvals landed ahead of their own clocks, the FDA launched a pilot explicitly designed to compress first-in-human timelines, and a $350 million IPO priced and opened without a pop — a week where the regulator moved faster than the market was willing to…